Skip to content
Trial Eligibility
Menu

Irritable Bowel Syndrome and Control Volunteers: Diet Challenge

NCT06668922

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The study will investigate the relationship between fecal bile acids, short-chain fatty acids (SCFAs), and the gut microbiota in irritable bowel syndrome (IBS). The central hypothesis of this study is that specific shifts in the GI microbiome composition correlate with altered colonic SCFAs and BAs and contribute to IBS symptoms.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Irritable Bowel Syndrome (IBS)

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, Los Angeles
Last updated on ClinicalTrials.gov
August 12, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, Los Angeles · Los Angeles, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.